New anxiety medication
There are several new anxiety medications that have been approved by the FDA in recent years. Here are a few examples:
- Brexanolone (Zulresso): This is a novel medication that is specifically approved for the treatment of postpartum depression with anxiety symptoms. It is a synthetic version of the hormone allopregnanolone, which is naturally produced by the body during pregnancy.
- Staccato loxapine (Zyprexa Zydis): This is a rapid-acting inhaled medication that is approved for the treatment of acute agitation associated with schizophrenia and bipolar disorder. It is also being studied for the treatment of anxiety disorders.
- Vortioxetine (Trintellix): This is a serotonin modulator that is approved for the treatment of major depressive disorder and generalized anxiety disorder. It works by affecting the levels of serotonin in the brain, which can help to reduce symptoms of anxiety.
- Vilazodone (Viibryd): This is a serotonin modulator that is approved for the treatment of major depressive disorder and generalized anxiety disorder. It works by affecting the levels of serotonin in the brain, which can help to reduce symptoms of anxiety.
- Lurasidone (Latuda): This is an atypical antipsychotic medication that is approved for the treatment of bipolar disorder and schizophrenia. It is also being studied for the treatment of anxiety disorders.
- Asenapine (Saphris): This is an atypical antipsychotic medication that is approved for the treatment of schizophrenia and bipolar disorder. It is also being studied for the treatment of anxiety disorders.
- Aripiprazole (Abilify): This is an atypical antipsychotic medication that is approved for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. It is also being studied for the treatment of anxiety disorders.
- Pitolisant (Nourianz): This is a histamine-3 receptor antagonist that is approved for the treatment of excessive daytime sleepiness associated with narcolepsy. It is also being studied for the treatment of anxiety disorders.
- Suvorexant (Belsomra): This is a dual orexin receptor antagonist that is approved for the treatment of insomnia. It is also being studied for the treatment of anxiety disorders.
- Lesogaberan (AZD6765): This is a calcium channel blocker that is being studied for the treatment of anxiety disorders. It works by affecting the levels of calcium in the brain, which can help to reduce symptoms of anxiety.
It's important to note that these medications are not all approved for the treatment of anxiety disorders, and some may have different indications or dosing regimens. Additionally, while these medications may be effective for some people, they may not work for everyone, and they may have side effects. It's important to talk to a healthcare provider before starting any new medication.